Skip to main content

CareDx: Chris Cournoyer

CareDx has named Chris Cournoyer to its board of directors. Cournoyer previously served as chairperson and CEO for precision medicine company N-of-One, vice president of clinical analytics at Optum, and president and chief operating officer of Picis (before it was acquired by Optum). Cournoyer has also held roles at Harte Hanks, Lotus, and IBM, where she served as vice president of global business transformation, has served on the boards of Stride Rite, GTECH, and BJ's Wholesale group, and has been a director for Emerson Hospital. 

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.